Thomas Spanberger

447 total citations
7 papers, 323 citations indexed

About

Thomas Spanberger is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Thomas Spanberger has authored 7 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Thomas Spanberger's work include Brain Metastases and Treatment (4 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Thomas Spanberger is often cited by papers focused on Brain Metastases and Treatment (4 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Thomas Spanberger collaborates with scholars based in Austria, Germany and Ireland. Thomas Spanberger's co-authors include Monika Hackl, Peter Birner, Georg Widhalm, Daniela Prayer, Karin Dieckmann, Matthias Preusser, Anna S. Berghoff, Gerda Ricken, Bernhard Mlecnik and Harald Heinzl and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and OncoImmunology.

In The Last Decade

Thomas Spanberger

4 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Spanberger Austria 3 246 193 133 56 43 7 323
Y. Kim United States 4 228 0.9× 254 1.3× 88 0.7× 17 0.3× 42 1.0× 7 316
Rituraj Upadhyay United States 9 116 0.5× 98 0.5× 78 0.6× 50 0.9× 25 0.6× 38 253
Eren Celik Germany 11 112 0.5× 128 0.7× 55 0.4× 68 1.2× 32 0.7× 25 270
Deepak Bhamidipati United States 11 104 0.4× 131 0.7× 109 0.8× 43 0.8× 18 0.4× 23 307
S. Sarangkasiri United States 8 363 1.5× 167 0.9× 131 1.0× 83 1.5× 11 0.3× 12 401
Kevin Lee Min Chua Singapore 10 211 0.9× 141 0.7× 41 0.3× 66 1.2× 21 0.5× 30 341
Cosette D. Champion United States 8 107 0.4× 117 0.6× 91 0.7× 25 0.4× 12 0.3× 10 264
Ewa Wasilewska-Teśluk Poland 5 121 0.5× 98 0.5× 38 0.3× 21 0.4× 44 1.0× 14 198
Yin-duo Zeng China 6 242 1.0× 326 1.7× 41 0.3× 13 0.2× 48 1.1× 8 404
A. Paix France 7 83 0.3× 115 0.6× 29 0.2× 61 1.1× 25 0.6× 12 257

Countries citing papers authored by Thomas Spanberger

Since Specialization
Citations

This map shows the geographic impact of Thomas Spanberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Spanberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Spanberger more than expected).

Fields of papers citing papers by Thomas Spanberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Spanberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Spanberger. The network helps show where Thomas Spanberger may publish in the future.

Co-authorship network of co-authors of Thomas Spanberger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Spanberger. A scholar is included among the top collaborators of Thomas Spanberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Spanberger. Thomas Spanberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Spanberger, Thomas. (2025). The management of modern targeted therapy for CLL in a patient with significant cardiac comorbidities—a case report. memo - Magazine of European Medical Oncology. 18(2). 101–103.
2.
Spanberger, Thomas, et al.. (2023). Management of malignant hypercalcemia in cancer patients—a short review. memo - Magazine of European Medical Oncology. 16(4). 263–267.
3.
Spanberger, Thomas. (2020). Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma. memo - Magazine of European Medical Oncology. 13(1). 55–59.
4.
Berghoff, Anna S., Elisabeth Fuchs, Gerda Ricken, et al.. (2015). Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. OncoImmunology. 5(1). e1057388–e1057388. 228 indexed citations
5.
Preusser, Matthias, Anna S. Berghoff, Elisabeth Fuchs, et al.. (2014). Association of tumor-infiltrating lymphocytes with brain edema and overall survival in brain metastases.. Journal of Clinical Oncology. 32(15_suppl). 2012–2012. 1 indexed citations
6.
Berghoff, Anna S., Thomas Spanberger, Aysegül Ilhan‐Mutlu, et al.. (2013). Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times. PLoS ONE. 8(2). e55464–e55464. 34 indexed citations
7.
Spanberger, Thomas, Anna S. Berghoff, Carina Dinhof, et al.. (2012). Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. Clinical & Experimental Metastasis. 30(4). 357–368. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026